000			01537 a2200385 4500
005			20250515100858.0
264		0	_c20080417
008			200804s 0 0 eng d
022			_a0022-2623
024	7		_a10.1021/jm0708735 _2doi
040			_aNLM _beng _cNLM
100	1		_aJohnson, Steven M
245	0	0	_aBiochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors. _h[electronic resource]
260			_bJournal of medicinal chemistry _cJan 2008
300			_a260-70 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAmyloid _xantagonists & inhibitors
650	0	4	_aBenzoxazoles _xchemical synthesis
650	0	4	_aCrystallography, X-Ray
650	0	4	_aCyclooxygenase 1 _xchemistry
650	0	4	_aCyclooxygenase Inhibitors _xchemical synthesis
650	0	4	_aHumans
650	0	4	_aIn Vitro Techniques
650	0	4	_aLiver _xmetabolism
650	0	4	_aModels, Molecular
650	0	4	_aPrealbumin _xantagonists & inhibitors
650	0	4	_aProtein Conformation
650	0	4	_aReceptors, Thyroid Hormone _xmetabolism
650	0	4	_aStructure-Activity Relationship
700	1		_aConnelly, Stephen
700	1		_aWilson, Ian A
700	1		_aKelly, Jeffery W
773	0		_tJournal of medicinal chemistry _gvol. 51 _gno. 2 _gp. 260-70
856	4	0	_uhttps://doi.org/10.1021/jm0708735 _zAvailable from publisher's website
999			_c17607949 _d17607949